Roche Signs RWD Collaboration with PicnicHealth to Create Personalized Treatment for Patients with Multiple Sclerosis


  • The real-world evidence partnership will allow the Roche to access PicnicHealth’s set of de-identified patient records to gain insights on certain diseases and treatments
  • The collaboration will initially focus on MS and may be extended to support Huntington’s disease (HD), paroxysmal nocturnal hemoglobinuria (PNH), and hemophilia
  • The companies signed a multi-year collaboration that combines over 7yrs. of retrospective medical record data with 5yrs. of prospective data for 5,000 MS patients, including clinical outcomes and MRI images, to explore the progression of the neurodegenerative disease and facilitate the development of personalized treatments

Click here to read full press release/ article | Ref: Businesswire | Image: Medcity News